Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BICYCLE THERAPEUTICS PLC | 2,122,892 | 2,339,961 | +217,069 | 42,967 | 52,953 | 9.09% | +9,986 |
| REPLIMUNE GROUP INC(REPL) | 4,866,449 | 4,866,449 | 0 | 43,798 | 53,336 | 9.16% | +9,538 |
| ENGENE HOLDINGS INC *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | 3,425 | 6,044 | 1.04% | +2,619 |
| ACHILLES THERAPEUTICS PLC | 2,390,050 | 2,390,050 | 0 | 1,948 | 2,438 | 0.42% | +490 |
| ENGENE HOLDINGS INC COM | 8,677,951 | 8,677,951 | 0 | 81,833 | 57,274 | 9.84% | -24,559 |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 11,831,461 | 11,831,461 | 0 | 227,282 | 196,402 | 33.73% | -30,880 |
| DYNE THERAPEUTICS INC(DYN) | 7,845,364 | 5,954,069 | -1,891,295 | 276,863 | 213,870 | 36.73% | -62,993 |